• Sponsorship Opportunities
  • Contributions
  • CEO Roundtable
  • Research Projects
  • Educational Seminars
• Industry Events
  • Center Educational Sessions
  • Specialty Pharmaceutical Supply Chain Issues and Trends
  • Supply Chain Security
• Resources
  • Talk of the Trade
  • Industry Analysts
  • Useful Links
• Data Management/ Data Sharing
  • Rules of Engagement: A Qualitative Business Case
  • Rules of Engagement: Phase II • The Blueprint for Data Management & Sharing
• Research Projects
  • Role of the Distributor
  • Role of the Specialty Distributor
  • HDMA Factbook
  • Risk Evaluation and Mitigation Strategies (REMS)
  • Specialty Trends
• Nexus Award
• Annual Report
•  

2012 Specialty Pharmaceuticals: Facts, Figures and Trends

Order the Fourth Edition of the Center’s Specialty Pharmaceuticals: Facts, Figures and Trends Now!

Specialty pharmaceutical sales continue to grow in the U.S, reaching $77.5 billion and accounting for about 24 percent of the total $320 billion prescription sales volume in 2011. As this market grows, specialty drugs are gaining increased attention from pharmaceutical manufacturers and distributors, payers, policymakers and providers.

Distributors, sometimes referred to as wholesalers, are distinguished by the channel they serve and account for the distribution of approximately 90 percent of all U.S. specialty drug sales volume. Specialty distributors play a unique role in addressing the needs of the specialty segment of the supply chain, and are responsible for approximately $30.5 billion of all U.S. specialty drugs sold in 2011.

Given the growing impact of the specialty pharmaceutical segment on the healthcare supply chain, the Center for Healthcare Supply Chain Research, the research foundation of the Healthcare Distribution Management Association, has for the fourth straight year compiled a research report titled Specialty Pharmaceuticals: Facts, Figures and Trends. The report highlights specialty trends and distributor performance metrics. The text includes benchmarks on the following: market characteristics, finance, operations, cold chain handling, transportation/delivery, information technology, returns and services, plus a chapter that takes a deeper dive into demographic trends and various disease states, like oncology.

Purchase your copy today!

Purchase your copy today!
Download the order form
Order your electronic version
View the Executive Summary
View the table of contents
Read the press release

For more information on bulk and bundling discounts or to organize a presentation to your staff on these findings, contact Karen Ribler at (703) 885-0256.

Sponsored by

PLATINUM
CuraScript Specialty Distribution
McKesson Specialty Health, a division of McKesson Corporation

GOLD
Genentech, a Member of the Roche Group
H.D. Smith Foundation
Intellogics

SILVER
Health Coalition, Inc.
SpecialtyFirst™
Sensitech Inc.
Takeda Pharmaceuticals U.S.A., Inc. (TPUSA)